The Continuing Urgency of The Opioid Crisis Requires Systems to Work Together - Harm Reduction, Prevention, Treatment, Social Services, Criminal Justice, as well as Payers - to Ensure Access to High-Quality Care.  

The Opioid Policy Research Collaborative serves as a primary resource for state and federal health officials, policymakers, and private organizations and play prominent roles in four key areas:

  • Providing cutting-edge research to objectively evaluate local, state and national interventions and policies implemented in response to the opioid crisis.
  • Offering evidence-based guidance and recommendations for a wide range of stakeholders, including federal, state and local government agencies, health care systems, and industry.
  • Serving as a convener and collaborator to bring together researchers, clinicians, and policymakers from diverse disciplines to develop coordinated strategies for responding to the opioid epidemic. The Collaborative creates opportunities for university faculty to collaborate with other experts in public health, health services research, epidemiology, addiction medicine, education, and drug policy. 
  • Communicating activities, outcomes, and accomplishments from innovative research and policy initiatives across academic, medical, nonprofit and government fields. The Collaborative works closely with media outlets to highlight key accomplishments for an even wider audience.

Bridging the Disparities Gap in the Opioid Crisis

In Heller Magazine, Maria Madison and Andrew Kolodny discuss how the prevailing narrative around the opioid addiction epidemic fails to recognize its effects on nonwhite populations.

OPRC in the News

Cover of Drug and Alcohol Dependence Journal

New Study Examines How Law Enforcement Officers Respond to Opioid Overdose Calls

The study, conducted by Dr. Traci Green and colleagues, was published in the journal Drug and Alcohol Dependence. 

Graphic of Black male face superimposed over pill capsules

Opioid Crisis Response Leaves Black Americans Behind

Despite the current epidemic being painted early on as one that impacts young white Americans, Dr. Andrew Kolodny and other physicians highlight how the opioid crisis response leaves Black Americans behind. 

Traci Green, Director of the Opioid Policy Research Collaborative

Examining Nonprescription Syringe Sales in MA and RI Community Pharmacies

Dr. Traci Green describes how new research reflects high uptake of nonprescription syringes in Massachusetts and Rhode Island retail pharmacies, in a study published in the Journal of the American Pharmacists Association.

Cover of AMA Journal of Ethics

VIEWPOINT: How FDA Failures Contributed to the Opioid Crisis

Dr. Andrew Kolodny explores how regulatory mistakes made by the FDA in approving and labeling new analgesics contributed to the opioid public health crisis and how they can be prevented in the future.